Our findings demonstrated that the expression of c-MET, RhoA, and CLD18 occurs frequently in GC and that the relationship between them and other biomarkers, such as HER2 and E-cadherin, may support the association of these markers with the subtypes of the molecular classification. The gene discussed is RHOA; the disease is gastric cancer.